Experts Explore How to Treat Each Stage of Triple-negative Breast Cancer
Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast...
Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast...
This week, scientists from around the world will convene in Orlando, Florida, as the AACR hosts a conference titled...
“Easing the Pain” tells the story of cancer patients’ experiences dealing with pain and best practices for pain management....
Many things come to mind at the mention of New Orleans—jazz, Cajun food, po’ boys, and French-inspired houses with...
The U.S. Food and Drug Administration (FDA) recently approved the use of molecularly targeted therapeutic afatinib (Gilotrif) for treating...
On April 19, Sven Bilke, PhD, staff scientist in the Genetics Branch of the National Cancer Institute, discussed his...
During a conference known for its emphasis on basic and translational science, a panel discussion on the Affordable Care...
The American Association for Cancer Research (AACR) has released its 2015 Annual Report, titled “Bringing Cancer Discoveries to Patients.”...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the antiangiogenic...
In a study presented at the AACR Annual Meeting 2016 on April 19, researchers engineered an organic bispecific adaptor...
Earlier this month, the U.S. Food and Drug Administration (FDA) approved a new colorectal cancer screening test, the ‘System,...